Woodline Partners LP raised its stake in Lam Research Co. (NASDAQ:LRCX – Free Report) by 3,779.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,152,450 shares of the semiconductor company’s stock after acquiring an additional 2,096,966 shares during the quarter. Lam Research comprises approximately 1.1% of Woodline Partners LP’s investment portfolio, making the stock its 7th biggest holding. Woodline Partners LP’s holdings in Lam Research were worth $155,471,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Centerpoint Advisors LLC increased its position in Lam Research by 900.0% in the 4th quarter. Centerpoint Advisors LLC now owns 1,000 shares of the semiconductor company’s stock valued at $72,000 after acquiring an additional 900 shares in the last quarter. Transform Wealth LLC bought a new position in shares of Lam Research in the 4th quarter valued at about $17,269,000. E. Ohman J or Asset Management AB bought a new position in shares of Lam Research in the 4th quarter valued at about $4,258,000. Huntington National Bank boosted its stake in shares of Lam Research by 944.0% in the 4th quarter. Huntington National Bank now owns 294,762 shares of the semiconductor company’s stock valued at $21,291,000 after purchasing an additional 266,527 shares during the last quarter. Finally, Trust Co. of Oklahoma boosted its stake in shares of Lam Research by 904.2% in the 4th quarter. Trust Co. of Oklahoma now owns 25,778 shares of the semiconductor company’s stock valued at $1,862,000 after purchasing an additional 23,211 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.
Insider Activity
In related news, SVP Seshasayee Varadarajan sold 110,080 shares of the business’s stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $90.00, for a total transaction of $9,907,200.00. Following the transaction, the senior vice president now directly owns 179,084 shares in the company, valued at approximately $16,117,560. The trade was a 38.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.29% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Read Our Latest Research Report on LRCX
Lam Research Price Performance
NASDAQ LRCX opened at $83.82 on Tuesday. The company has a quick ratio of 1.73, a current ratio of 2.54 and a debt-to-equity ratio of 0.51. Lam Research Co. has a 12-month low of $56.32 and a 12-month high of $113.00. The company has a market capitalization of $107.22 billion, a PE ratio of 25.46, a price-to-earnings-growth ratio of 1.47 and a beta of 1.64. The firm’s 50 day moving average is $72.50 and its 200-day moving average is $75.53.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The semiconductor company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Lam Research had a net margin of 26.49% and a return on equity of 51.86%. The company had revenue of $4.72 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period last year, the company earned $7.79 earnings per share. The firm’s revenue was up 24.4% compared to the same quarter last year. Equities research analysts anticipate that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
- Five stocks we like better than Lam Research
- A Deeper Look at Bid-Ask Spreads
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- How to Effectively Use the MarketBeat Ratings Screener
- What Ray Dalio’s Latest Moves Tell Investors
- What Are Treasury Bonds?
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.